30 Sept 2026, 11:58 pmCompany Update
Sale Of Shares Of Subsidiary Company Under Regulation 30 Of SEBI LODR 2015
General PDF
Indrayani Biotech Ltd operates in Other Agricultural Products within the Consumer Staples sector.
1,655 historical price candles were omitted because the exchange source has not been verified.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
Consolidated figures
| Ratio | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross margin % | 25.2% | 33.3% | 37.3% | 41.6% | 36.4% | 31.7% |
| EBITDA margin % | -23.5% | 11% | 10.6% | 14.1% | 4.8% | 7% |
| EBIT margin % | -25.7% | 9.9% | 8.5% | 11.8% | 2.2% | 3.9% |
| PAT margin % | -53.2% | 7.2% | 7.3% | 6.3% | -4.7% | 1.4% |
| Working capital | ||||||
| Receivable days | 83 | 84 | 67 | 87 | 164 | 155 |
| Inventory days | 25 | 14 | 44 | 159 | 182 | 147 |
| Payable days | 81 | 58 | 81 | 141 | 104 | 55 |
| NWC days | 26 | 39 | 30 | 105 | 243 | 247 |
| Leverage | ||||||
| Current ratio | 0.77 | 0.97 | 1.08 | 1.67 | 1.74 | 1.71 |
| Debt to EBITDA | — | 2.64 | 3.64 | 4.59 | 21.9 | 13.32 |
| Debt to equity | 0.79 | 0.74 | 1.14 | 1.6 | 1.89 | 1.76 |
| Interest coverage | -2.6 | 3.4 | 3.3 | 2.1 | 0.5 | 1 |
| Asset turnover | 0.53 | 1.2 | 1.04 | 0.71 | 0.49 | 0.54 |
| Return ratios | ||||||
| Return on assets % | -28% | 8.6% | 7.6% | 4.4% | -2.3% | 0.8% |
| Return on capital employed % | -18.2% | 21% | 31.7% | 18% | 3.8% | 6.1% |
| Return on equity % | -56.8% | 18.4% | 21.7% | 15.5% | -8.4% | 2.7% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
No scheme among the 32 fund houses on record reported a position in Indrayani Biotech Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
Documents link to external sources (exchange filings, company investor pages).
| Holder (%) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.84% | 44.74% | 42.13% | 33.48% | 33.4% | 33.28% | 33.28% | 33.28% | 33.26% | 33.26% | 33.26% | 32.92% | |
| FII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 13.11% | 10.09% | 8.47% | 6.79% | 5.59% | 5.25% | 3.66% | 3.11% | 3.13% | 3.13% | 3.13% | 3.13% | |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 42.05% | 45.17% | 49.4% | 59.73% | 61.01% | 61.47% | 63.06% | 63.61% | 63.61% | 63.61% | 63.61% | 63.95% | |
| No. of shareholders | — | — | — | — | — | — | — | — | 25,686 | 25,565 | 25,509 | 25,811 |
Promoter holding down 11.92 percentage points since Sep 2023.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 5 Jun 2026 | VITRAG SEVENTEEN FAMILY TRUST | Bulk | BSE | Buy | 4,00,000 | ₹11.45 | ₹0.46 Cr |
| 5 Jun 2026 | AMBA INVESTORS AOP | Bulk | BSE | Sell | 4,00,000 | ₹11.45 | ₹0.46 Cr |
| 6 Nov 2025 | GURURAJ PRIYADARSHINI | Bulk | BSE | Buy | 3,00,944 | ₹15.44 | ₹0.46 Cr |
| 28 Mar 2025 | PARIMALA KRISHNAMURTHY | Bulk | BSE | Buy | 2,98,500 | ₹14.14 | ₹0.42 Cr |
| 28 Mar 2025 | NEXT ORBIT VENTURES FUND | Bulk | BSE | Sell | 2,50,000 | ₹14.14 | ₹0.35 Cr |
| 27 Mar 2025 | LRSD SECURITIES PRIVATE LIMITED | Bulk | BSE | Buy | 2,50,000 | ₹14.82 | ₹0.37 Cr |
| 27 Jun 2024 | NEXT ORBIT VENTURES FUND | Bulk | BSE | Sell | 10,00,000 | ₹58.86 | ₹5.89 Cr |
| 27 Jun 2024 | RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED | Bulk | BSE | Buy | 9,52,945 | ₹58.60 | ₹5.58 Cr |
| 27 Jun 2024 | TOPGAIN FINANCE PRIVATE LIMITED | Bulk | BSE | Buy | 3,51,626 | ₹59.46 | ₹2.09 Cr |
| 27 Jun 2024 | SAHASTRAA ADVISORS PRIVATE LIMITED | Bulk | BSE | Sell | 2,67,714 | ₹58.60 | ₹1.57 Cr |
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Lt Foods LimitedLTFOODSLTFOODS | ₹13,862 Cr | ₹14,836 Cr | ₹11,633 Cr | ₹1,247 Cr | 10.6% | ₹640 Cr | 5.7% | 20.1% | 14.9% | 176 |
| Krbl LimitedKRBLKRBL | ₹8,604 Cr | ₹8,774 Cr | ₹6,009 Cr | ₹992 Cr | 14.8% | ₹758 Cr | 10.6% | 15.5% | 11.7% | 323 |
| Gujarat Ambuja Exports LimitedGAELGAEL | ₹7,233 Cr | ₹7,667 Cr | ₹6,032 Cr | ₹602 Cr | 8.1% | ₹416 Cr | 5.3% | 13.2% | 9.7% | 84 |
| Trualt Bioenergy LimitedTRUALTTRUALT | ₹3,812 Cr | ₹5,458 Cr | ₹2,051 Cr | ₹381 Cr | 16.8% | ₹149 Cr | 5.6% | 10.8% | 6.3% | 170 |
| Kaveri Seed Company LimitedKSCLKSCL | ₹3,676 Cr | ₹3,676 Cr | ₹1,279 Cr | ₹292 Cr | 24.2% | ₹250 Cr | 21.2% | 18.2% | 18.2% | 396 |
| Amir Chand Jagdish Kumar (Exports) LimitedAEROPLANEAEROPLANE | ₹2,156 Cr | ₹2,914 Cr | ₹2,287 Cr | ₹225 Cr | 9.9% | ₹103 Cr | 4.5% | 24.1% | 11.2% | 253 |
| Sanstar LimitedSANSTARSANSTAR | ₹2,063 Cr | ₹2,083 Cr | ₹821 Cr | ₹54 Cr | 4.8% | ₹44 Cr | 4.4% | 5.5% | 5.1% | 53 |
| Grm Overseas LimitedGRMOVERGRMOVER | ₹1,613 Cr | ₹1,979 Cr | ₹1,869 Cr | ₹102 Cr | 5.1% | ₹77 Cr | 4.2% | 23.7% | 14.5% | 212 |
| Chaman Lal Setia Exports LimitedCLSELCLSEL | ₹1,401 Cr | ₹1,484 Cr | ₹1,478 Cr | ₹171 Cr | 10.9% | ₹125 Cr | 8% | 19% | 14.6% | 197 |
| Avt Natural Products LimitedAVTNPLAVTNPL | ₹1,338 Cr | ₹1,452 Cr | ₹822 Cr | ₹114 Cr | 12.6% | ₹84 Cr | 9.1% | 16.9% | 12.2% | 327 |
| Gulshan Polyols LimitedGULPOLYGULPOLY | ₹1,009 Cr | ₹1,401 Cr | ₹2,260 Cr | ₹134 Cr | 4.7% | ₹43 Cr | 1.2% | 7.5% | 4.1% | 49 |
| Regaal Resources LimitedREGAALREGAAL | ₹883 Cr | ₹1,493 Cr | ₹1,090 Cr | ₹133 Cr | 11.2% | ₹60 Cr | 4.9% | 15% | 15.2% | 50 |
Sale Of Shares Of Subsidiary Company Under Regulation 30 Of SEBI LODR 2015
Board Meeting Intimation For Board Meeting Intimation For Intimation For Board Meeting To Be Held On 7Th October, 2026
Closure of Trading Window
Announcement under Regulation 30 (LODR)-Newspaper Publication
Letter Of Offer For Rights Issue
Corporate Action-Outcome of Right issue
Appointment of Company Secretary and Compliance Officer
Resignation Of Secretarial Auditor.
| Date | Category | Subject | Filing |
|---|---|---|---|
| 30 Sept 2026, 11:58 pm | Company Update General | Sale Of Shares Of Subsidiary Company Under Regulation 30 Of SEBI LODR 2015 | |
| 30 Sept 2026, 6:04 pm | Board Meeting | Board Meeting Intimation For Board Meeting Intimation For Intimation For Board Meeting To Be Held On 7Th October, 2026 |
| 29 Sept 2026, 12:31 pm | Insider Trading / SAST Closure of Trading Window | Closure of Trading Window |
| 15 Sept 2026, 11:56 am | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 9 Sept 2026, 8:29 pm | Company Update General | Letter Of Offer For Rights Issue |
| 9 Sept 2026, 8:22 pm | Corp. Action Bonds / Right issue | Corporate Action-Outcome of Right issue |
| 9 Sept 2026, 7:05 pm | Company Update Appointment of Company Secretary / Compliance Officer | Appointment of Company Secretary and Compliance Officer |
| 7 Sept 2026, 6:42 pm | Company Update General | Resignation Of Secretarial Auditor. |
Consolidated figures · ₹ crore
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 21 | 62 | 163 | 166 | 130 | 138 | |
| COGS | 16 | 41 | 102 | 97 | 83 | 94 |
| Gross profit | 5 | 21 | 61 | 69 | 47 | 44 |
| 10 | 14 | 43 | 46 | 41 | 34 | |
| -5 | 7 | 17 | 23 | 6 | 10 | |
| OPM % | -23.5% | 11% | 10.6% | 14.1% | 4.8% | 7% |
| Depreciation | 0 | 1 | 3 | 4 | 3 | 4 |
| Interest | 2 | 2 | 6 | 10 | 12 | 10 |
| -4 | 0 | 4 | 1 | 3 | 5 | |
| Profit before tax | -11 | 4 | 12 | 11 | -6 | 0 |
| Tax | 0 | 0 | 0 | 1 | 0 | -2 |
| Tax % | 0% | 0% | 3.1% | 5% | 6.3% | -553.3% |
| -11 | 4 | 12 | 10 | -6 | 2 | |
| PAT margin % | -53.2% | 7.2% | 7.3% | 6.3% | -4.7% | 1.4% |
| EPS (₹) | -3.2 | 1.3 | 2.6 | 1.4 | -1.4 | 0.5 |
| EPS adjusted (₹) | -3.3 | 1.3 | 2 | 2.3 | -1.3 | 0.1 |
| Annual report | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 34 | 34 | 43 | 46 | 46 | 46 |
| Reserves | -15 | -10 | 12 | 22 | 27 | 27 |
| Minority interest | 0 | 0 | — | 9 | 27 | 29 |
| 16 | 18 | 63 | 108 | 137 | 128 | |
| 4 | 9 | 38 | 51 | 31 | 23 | |
| Total equity & liabilities | 40 | 51 | 156 | 235 | 268 | 253 |
| 15 | 17 | 57 | 62 | 58 | 60 | |
| CWIP | 14 | 13 | 14 | 20 | 26 | 27 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| 11 | 22 | 85 | 152 | 185 | 166 | |
| Total assets | 40 | 51 | 156 | 235 | 268 | 253 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 0 | 4 | 16 | -30 | -7 | 32 | |
| -1 | -1 | -47 | -16 | 25 | -13 | |
| -0 | -3 | 33 | 44 | -18 | -15 | |
| Net cash flow | -1 | 1 | 2 | -2 | -0 | 4 |
| Free cash flow | — | — | -2 | -47 | -8 | 24 |
| CFO / Operating profit % | — | 60.7% | 94% | -129.5% | -107.7% | 331.8% |